Faculty of Medicine and Health Sciences.
MindSpot Clinic.
Rehabil Psychol. 2019 Aug;64(3):263-268. doi: 10.1037/rep0000262. Epub 2019 Feb 28.
To report on the effect of involvement in civil litigation on outcome for patients enrolled in a validated Internet-delivered pain management program, the Pain Course.
Data from a randomized controlled trial (RCT) on the effect of varying levels of clinician support was used to examine the effect of involvement in civil litigation on outcome in a free online pain management course. Outcome measures were changes in scores on self-report questionnaires for depression, anxiety, and disability (PHQ-9, GAD-7, and RMDQ) from baseline to 3-month follow-up for those still involved in litigation and those who had completed litigation, compared with outcomes for those who did not report involvement in litigation. The use of regular and as-required opioid medication at assessment and follow-up were also compared.
Of the 397 patients enrolled in the pain course, 290 (73.0%) were not involved in litigation, 80 (20.2%) reported involvement in litigation that had been resolved and 27 (6.8%) reported ongoing litigation. Those still involved in litigation had the highest scores on depression scales and the highest rate of opioid use. The completion rates and symptom improvement was lower among current litigants but were still positive, with effect sizes on the outcome measures of between 0.56 and 0.73, as well as a reduction in the use of opioids.
Current involvement in compensation litigation was associated with lower treatment completion and less symptom improvement. Nevertheless, the positive findings have significant implications for people involved in workers' compensation and other litigation who report pain as one of their symptoms. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
报告参与民事诉讼对参加经过验证的互联网疼痛管理计划(疼痛课程)的患者结局的影响。
利用一项关于不同程度临床医生支持对在线疼痛管理课程效果的随机对照试验(RCT)的数据,研究民事诉讼参与对免费在线疼痛管理课程中结局的影响。结局测量指标为基线至 3 个月随访时的抑郁、焦虑和残疾自我报告问卷(PHQ-9、GAD-7 和 RMDQ)评分的变化,与未报告民事诉讼参与的患者相比,那些仍在参与民事诉讼和已完成民事诉讼的患者的结局。同时比较评估和随访时常规和按需阿片类药物的使用情况。
在参加疼痛课程的 397 名患者中,290 名(73.0%)未参与民事诉讼,80 名(20.2%)报告已解决的民事诉讼参与,27 名(6.8%)报告正在进行的民事诉讼。仍在参与民事诉讼的患者抑郁量表得分最高,阿片类药物使用率最高。目前正在参与诉讼的患者完成治疗的比例和症状改善率较低,但仍为阳性,结局测量指标的效应大小在 0.56 至 0.73 之间,阿片类药物的使用也减少了。
目前参与赔偿诉讼与治疗完成率较低和症状改善较少有关。尽管如此,这些积极的发现对参与工人赔偿和其他诉讼并报告疼痛作为其症状之一的人具有重要意义。